The Medical Research Council (MRC) has launched a new £5m call for capital investment to support between two and five human tissue banks with linked data resources. Awards will be made to teams of academics working in close partnership with medical research charities.
It's estimated that about half of people admitted to hospital with a stroke will have lost control of their bladder, and a third will experience loss of bowel control. Last week, a research incontinence workshop was held at Guy's Hospital London, with the aim of stimulating research into incontinence.
CADASIL is one of the most common genetic causes of stroke and dementia. Currently, there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
New research review suggests that post-stroke fatigue is a symptom independent of depression, pain and sleep problems, and may depend on the 'excitability' of the movement part of the brain.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC), which is the national membership organisation of leading medical and health research charities in the UK. Published today, the AMRC's 'Making a difference: Impact report 2017' highlights how the research of its member charities makes a difference.
These summaries of our completed research projects highlight what work was undertaken, which aims were achieved and where the research is going next.
Published in the journal, Neurorehabilitation and Neural Repair, a new Stroke Association funded study suggests people who are in the chronic stages of stroke will improve their reaching accuracy at the speed at which they train their reaching movement.
UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway.
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
This study will test arm training to encourage a functionally useful contribution to recovery from the side of the brain unaffected by stroke (the 'non-stroke hemisphere'), and whether this is only possible early after stroke.